Publications - FIDMAG, Fundation for research

COOKIES USE
We use necessary system cookies for the correct functioning of the website and optional Google Analytics cookies to obtain visit statistics. +info

Cookies config

Necessary

The necessary cookies are absolutely essential for the website to work properly. This category only includes cookies that guarantee basic website security and functionality. These cookies do not store any personal information.

Name	Proveedor	Propiedad	Finalidad	Caducidad
_GRECAPTCHA	google.com	Own	provide antispam protection with the reCaptcha service	6 months
cc_cookie_accept	fidmag.org	Own	Usada per confirmar que l'usuari ha confirmat / refusat les cookies (i quins tipus accepta)	1 any
WEB_SESSION	fidmag.org	Own	Cookie técnica: cookie de sessió PHP. Guarda l'id de sessió d'usuari.	al acabar la sessió

Analisys

Analytical cookies are used to understand how visitors interact with the website. These cookies help to provide information on meters, the name of visitors, the percentage of bounces, the font of the traffic, etc.

Name	Proveedor	Propiedad	Finalidad	Caducidad
_ga	Google Analytics	From third parties	Cookie d'anàlisi o mesurament: Identifica els usuaris i proporciona informació sobre com els usuaris troben la pàgina web i com la utilitzen per a realització d'Informes estadístics	2 anys
_gat_gtag_UA_141706552_1	Google Analytics	From third parties	Cookie d'anàlisi o mesurament: Tracking per part de google per google analytics	1 minut
_gid	Google Analytics	From third parties	Cookie d'anàlisi o mesurament: S'usa per limitar el percentatge de sol·licituds	24 hores

Configure Reject all Accept

Home
> Research

Back to results

FI
2.456

25438028

2014 International Clinical Psychopharmacology

Successful treatment of hydroxyzine and dexclorfeniramine maleate in combination with electroconvulsive therapy in a neuroleptic malignant catatonia: a case report.

Fernández-Corcuera P, Madre-Rull M, Amann BL

Limited service to collaborators of the network of Sisters Hospitalarias Centers. You will receive a message in your email with a link to download this article.

Abstract

Malign neuroleptic syndrome is a potentially life-threatening condition that is normally treated with electroconvulsive therapy (ECT). In this case report, we discuss a severely agitated and catatonic bipolar I patient who developed a neuroleptic malignant syndrome and did not improve with benzodiazepines and ECT. On the basis of anecdotal reports of the positive effects of antihistamines in psychosis and ECT, we treated our case with a combination of two antihistamines, hydroxyzine and dexclorfeniramine maleate, and ECT, which improved the clinical picture to the point of clinical remission.